PARA/DEXT/FENI SOL PED 30ML LGEN MONTELUKAST No administrar por vía intravenosa

Description

No administrar por vía intravenosa ni intramuscular

Tratamiento del carcinoma urotelial superficial de vejiga

KADCYLA® 160 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)

Tratamiento y prevención de trombosis venosa profunda (TVP)

PARA/DEXT/FENI SOL PED 30ML LGEN MONTELUKAST No administrar por vía intravenosa

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy